Andrew C.T. C. Ha

Cardiac Electrophysiology
Toronto General Hospital, Canada

Bayer (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)BMS/Pfizer (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)Servier (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)

Poster(s):

• (P041) THE IMPACT OF STATIN ON POST-OPERATIVE ATRIAL FIBRILLATION AFTER DISCHARGE FROM CARDIAC SURGERY: SECONDARY ANALYSIS OF THE SEARCH-AF CARDIOLINK-1 RANDOMIZED TRIAL
  Friday, October 28, 2022

  6:00 PM – 6:10 PM EDT

• (P065) BI-ATRIAL MAPPING AND ELEVATED HEART RATES IDENTIFY ABNORMAL ATRIAL SUBSTRATE IN ATRIAL FIBRILLATION PATIENTS WITHOUT LOW-VOLTAGE AREAS IN THE LEFT ATRIUM
  Friday, October 28, 2022

  12:00 PM – 12:10 PM EDT

• (P083) SEX DIFFERENCES IN ATRIAL FIBRILLATION AND ATRIAL STRUCTURAL REMODELLING: INSIGHTS FROM HIGH-RESOLUTION BI-ATRIAL ELECTROANATOMIC MAPPING
  Friday, October 28, 2022

  6:20 PM – 6:30 PM EDT

• (P164) IMPACT OF DIABETES AND GLUCOSE-LOWERING THERAPY ON POST-OPERATIVE ATRIAL FIBRILLATION AFTER CARDIAC SURGERY: SECONDARY ANALYSIS OF THE SEARCH-AF CARDIOLINK-1 RANDOMIZED CLINICAL TRIAL
  Saturday, October 29, 2022

  12:20 PM – 12:30 PM EDT